LIPOSOMAL MELATONIN 60MG

While melatonin is widely known for regulating sleep, high-dose therapy—often exceeding 100 mg—is being studied for its potential "oncostatic" (cancer-inhibiting) properties. Using a liposomal delivery system is a specific strategy to bypass the limitations of standard oral supplements.

​Here is an explanation of the mechanisms and why the liposomal format is used in this context.

​1. The Liposomal Advantage

​Standard melatonin capsules have low bioavailability (often only 10–15%) because they are heavily processed by the liver before entering the bloodstream.

• ​Bioavailability: Liposomal formulations encapsulate melatonin in tiny fat bubbles (lipid vesicles) that protect it from stomach acid and bypass the liver's first-pass metabolism.

• ​Intracellular Delivery: Because liposomes mimic the body’s cell membranes, they can fuse directly with cells, delivering the melatonin directly into the cytoplasm and mitochondria where its antioxidant effects are most potent.

​2. Core Anti-Cancer Mechanisms

​At high doses, melatonin moves beyond sleep regulation and acts as a powerful bioactive molecule:

• ​Apoptosis Induction: Melatonin can trigger "programmed cell death" in cancer cells by increasing oxidative stress specifically within the tumor, while simultaneously protecting healthy cells.

• ​The Warburg Effect Reversal: Cancer cells often switch to a less efficient metabolism to fuel rapid growth (the Warburg Effect). High-dose melatonin can suppress this metabolic shift, essentially "starving" the tumor's energy production.

• ​Anti-Angiogenesis: It has been shown to inhibit the formation of new blood vessels that tumors need to grow and spread (metastasis).
• ​Immune Modulation: It can enhance the activity of Natural Killer (NK) cells and T-lymphocytes, which are the body's primary defense against malignant cells.

​3. Synergistic Effects with Standard Care

​Clinical research often focuses on melatonin as an adjuvant (add-on) therapy:

• ​Radiosensitization: It may make cancer cells more sensitive to radiation while protecting surrounding healthy tissue from damage.
• ​Reduced Toxicity: Studies have suggested that high-dose melatonin can reduce the side effects of chemotherapy, such as fatigue, nausea, and bone marrow suppression.

​4. Safety and Considerations

​A dose of 120 mg is significantly higher than the standard 1–5 mg used for sleep.

• ​Non-Toxic Profile: Most studies indicate that even very high doses of melatonin are remarkably non-toxic to healthy cells.

• ​1. Prostate Cancer (PCa)

  ​Research identifies prostate cancer as highly sensitive to melatonin because it modulates both metabolic and hormonal pathways.

  • ​Androgen Receptor Modulation: Melatonin can physically interfere with androgen receptors, essentially helping to "block" the signals that drive prostate cancer growth.
  • ​Survival Rates: A significant clinical study (re-evaluated in late 2024) observed that in patients with poor-prognosis prostate cancer, those taking melatonin alongside hormone and radiation therapy had a median overall survival of 153.5 months, compared to 64 months in the control group.
  • ​Metabolic Starvation: It acts as a competitive inhibitor of GLUT1, a transporter that cancer cells use to gorge on glucose. By blocking this, melatonin helps starve the tumor cells of their primary fuel.